GAPDH Antibody from SICGEN ANTIBODIES
Search, find, compare suppliers for anti-GAPDH antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | GAPDH |
| Clone | polyclonal |
| Host Species | Goat |
| Reactive Species | human, mouse, rat, bovine, canine, chicken/avian, donkey, feline, goat, guinea pig, hamster, horse, porcine, rabbit, sheep, simian |
| Isotype | n/a |
| Format | epitope affinity purified |
| Size | 400 µg |
| Concentration | 2 mg/ml |
| Applications | WB, IF, IHC-P, IHC-F |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | RRID: AB_2333143. Goat polyclonal to GAPDH (glyceraldehyde 3-phosphate dehydrogenase). GAPDH catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains. Detects a band of 37 kDa by Western blot in the following human (293A, HMEC-1, U-118, HaCat), rat (TR-iBRB), mouse (AtT-20, Hepa), canine (D17) and monkey (COS-7) whole cell lysates. |
| Immunogen | Purified recombinant peptide derived from within residues 240 aa to the C-terminus of human GAPDH produced in E. coli. |
| Other Names | glyceraldehyde 3-phosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, G3PD, GAPD, HGNC:4141, GAPDH antibody. |
| Gene, Accession # | Accession: ENSG00000111640 |
| Catalog # | AB0067-200 |
| Price | 320 € |
| Order / More Info | GAPDH Antibody from SICGEN ANTIBODIES |
| Product Specific References | 1. Ramos S, Ademolue TW, Jentho E, et al. Cell Metab 2022 Aug. PMID: 35841892 2. Broughton K, Korski K, Echeagaray O, et al. Gene Ther. 2019 Aug. PMID:31239537 3. Korski KI, Kubli DA, Wang BJ, et al. Stem Cells. 2019 Jan. PMID:30629785 4. Broughton K, Korski K, Echeagaray O, et al. bioRxiv 521732; Jan 2019 5. Korski KI,MSc Thesis, Univ San Diego, USA, 2018 6. Choudhury SS, MSc Thesis, Univ San Diego, USA, 2018 7. Sacchi V, Wang BJ, Kubli D, et al. J Am Heart Assoc. 2017 Oct (Supplemental Information). PMID:29018025 8. Khalafalla FG, Kayani W, Kassab A, et al. J Physiol. 2017 Oct. PMID:28980705 9. Firouzi F, MSc Thesis, San Diego State University, USA, 2017 10. Goncalves A, Lin CM, Muthusamy A, et al. Invest Ophthalmol Vis Sci. 2016 May. PMID: 27163772 11. Hyenne V, Apaydin A, Rodriguez D, et al. J Cell Biol. 2015 Oct. PMID: 26459596 12. Helsby MA, Leader PM, Fenn JR. BMC Cell Biol. 2014 Feb. PMID: 24528853 13. Grilo MLJ, MSc Thesis, University of Coimbra, Portugal, 2014 14. Matos CTSM, PhD Thesis, NOVA University of Lisbon, Portugal, 201313. Grilo MLJ, MSc Thesis, University of Coimbra 2014 14. Matos CTSM, PhD Thesis, NOVA University of Lisbon, Portugal, 2013 |
SICGEN ANTIBODIES
SICGEN ANTIBODIES
Research and Development in Biotechnology Ltd
BIOCANT PARK Nucleo 04, Lt 03
3060-196 Cantanhede PORTUGAL
P: +351 91 9145219
F: +351 21 458 21 89
information@sicgen.pt
Technical Support: technical@sicgen.pt
http://www.sicgen.pt
Profile of SICGEN ANTIBODIES
Return to Antibodies